Navigation Links
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
Date:1/5/2009

, ventricular tachycardia (1.1 percent), and cardiogenic shock (1 percent).

NEXTERONE is contraindicated in patients with known hypersensitivity to any of the components of NEXTERONE, including iodine, or in patients with cardiogenic shock, marked sinus bradycardia, and second- or third-degree AV block unless a functioning pacemaker is available.

NEXTERONE is for hospital use only. NEXTERONE should be administered only by physicians who are experienced in the treatment of life-threatening arrhythmias, who are thoroughly familiar with the risks and benefits of intravenous amiodarone therapy, and who have access to facilities adequate for monitoring the effectiveness and side effects of treatment.

For more information about NEXTERONE, including full prescribing information, visit http://www.prismpharma.com.

About Prism Pharmaceuticals

Prism Pharmaceuticals, based in King of Prussia, Pennsylvania, is a specialty pharmaceutical company committed to developing and commercializing acute care cardiovascular products. The product portfolio strategy is focused on recognizing unfulfilled opportunities in existing compounds that address current unmet medical needs with a specific focus on medication safety in the hospital environment.

Prism was started in 2004 with a founding investment from Essex Woodlands Health Ventures (http://www.ewhv.com). In 2006 Prism secured a $68M layered financing of equity from Essex combined with equity and a revenue interest agreement from Paul Capital (http://www.paulcap.com). This level of sustaining investment has enabled Prism to pursue an aggressive licensing and rapid development model resulting in the successful approval of NEXTERONE.

The worldwide rights to NEXTERONE w
'/>"/>

SOURCE Prism Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
2. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
3. Prism glasses expand the view for patients with hemianopia
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...SHINGTON, Nov. 9 The Churchill C...Award For Leadership to J.W. "Bill" Marriott for h...ugh progressive free market practices and fosterin... Mr. Marriott will receive his award at a ceremony...ton D.C. Four Seasons Hotel. ,, "This is a tes...
(Date:11/9/2009)...elped men and women almost equally, study finds, ...he widely used clot-dissolving drug Plavix (clopid... analysis of major clinical trials has found. ,...in treating both men and women with this very impo...of cardiovascular thrombosis at New York Universit...
(Date:11/9/2009)...on of plans finds differences in mood despite simi...thDay News) -- Both a high-fat, low-carbohydrate d...at, high-carb diet appear to help people lose poun...d? Only the low-fat diets will result in long-term...Nov. 9 issue of Archives of Internal Medicine . ,...
(Date:11/9/2009)... Tomorrow may be too late when it...tion, according to TOPS Club, Inc. (Take Off Pound...anization. , (Vocus) Nove...omes to preventing or improving a diabetes conditi...Sensibly), the nonprofit weight-loss support organ...
(Date:11/9/2009)...BANON, Tenn., Nov. 9 Health Connec...nced it will host their inaugural Hospital O.R. an... at the Marriott Renaissance Hotel in Nashville, T...re than 100 hospital operating room directors and ...alth systems in the country. Some of the confirmed...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2
... your hotel stay, there is something right under y... Scientists //have warned that people with runny n...e everything they touch absorbs the Oh, so friendl...t with. While studying 15 people suffering cold, r...
...mited to the use of the newer painkillers called C...and the recently discontinued Vioxx and Bextra.// ...ntirely blameless, reports the October 2006 issue ... and COX-2s all belong to the class of medicines c...
... get the consent of one or both parents before hav... teens//, according to a Florida State University ...lick, the Jeffrey A. Stoops Professor of Law, and ... girls as a measure of risky sex in connection to ...
...he “strong, silent type” and the stigma of depress...ely than women to be referred to studies of depres...ognize and express symptoms of depression, accordi...s some of the strongest evidence to date that depr...
...e Conference, researchers revealed that amphetamin...vels and is currently the worst globally. // ... problem for Australia. The health of these countr...d Nations Office of Drugs and Crime told AFP. ...
...itself a polio-free state as another detection has... this despite the fact that the victim was adminis...cted in the past. "A fresh polio case has co...were given the drops," an official said. "Whil...
Other Medicine News:Health News:Abortion Notification, Consent Laws Reduce Risky Teen Sex 2Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 2Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 3Health News:Stereotypes Contribute to Older Men Seeking, Receiving Depression Care Less Frequently 4
(Date:11/9/2009)...ION, N.J., Nov. 9 Unwavering from ...s, but recognizing today,s economic climate, Lutro...thetic laser systems, introduces the MOSAIC CO2, a...er $50,000. ,, The MOSAIC CO2 offers many of t...logy including scanning and stamping operation mod...
(Date:11/9/2009)... Nov. 9 Decision Resources, one of...or pharmaceutical and healthcare issues, finds tha... 2 (HER2) targeting therapies -- which include Roc...ayaku,s Tykerb/Tyverb -- were the highest-selling ...ptake of Herceptin and Tykerb/Tyverb and the expec...
(Date:11/9/2009)... Nov. 9 ARmark Authentication Tech...an alliance in the development and introduction of...ion technology that incorporates microscopic cover...ngs of solid oral dosage forms (SODFs) to prevent ...lusive rights to market ARmark,s micro-tags for ta...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Research breakthrough will lead to more accurate weather forecasts 13460 1Research breakthrough will lead to more accurate weather forecasts 13460 2Mental Activity Seems to Keep the Brain Vital 54005 1Mental Activity Seems to Keep the Brain Vital 54005 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 1The Sloane Clinic pioneers Ultherapy in Singapore 54003 2The Sloane Clinic pioneers Ultherapy in Singapore 54003 3
...ntinues to anticipate CHMP opinion in the third qu...mission decision in the fourth ...Pharma, Inc.,(Nasdaq: IDMI ) today announced that...requested additional data analyses from the Phase ...o complete the additional data,analyses, respond t...
...ss., July 1 Echo Therapeutics,Inc. (OTC Bulletin ... a,clinical study of its Symphony(TM) Transdermal ... in patients with Type 1 and Type 2,diabetes. The ...ts of the,study in the third quarter of 2008. Echo...ts Prelude(TM) SkinPrep System, which incorporates...
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 2Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes 3
Shandon Slide Drying Hotplate
Liquichek Blood Gas Plus CO-Oximeter Control (Radiometer)
Liquichek Blood Gas Plus CO-Oximeter Control (IL)
Liquichek Cardiac Markers Control
Medicine Products: